vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Evercore Inc. (EVR). Click either name above to swap in a different company.
Evercore Inc. is the larger business by last-quarter revenue ($1.4B vs $950.5M, roughly 1.5× Astrana Health, Inc.). Evercore Inc. runs the higher net margin — 23.0% vs 0.7%, a 22.3% gap on every dollar of revenue. On growth, Evercore Inc. posted the faster year-over-year revenue change (98.8% vs 42.9%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 42.2%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Evercore Inc., formerly known as Evercore Partners, is a global independent investment banking advisory firm founded in 1995 by Roger Altman, David Offensend, and Austin Beutner. The firm has advised on over $4.7 trillion of merger, acquisition, and restructuring transactions since its founding.
ASTH vs EVR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.4B |
| Net Profit | $6.6M | $322.7M |
| Gross Margin | — | — |
| Operating Margin | 1.9% | — |
| Net Margin | 0.7% | 23.0% |
| Revenue YoY | 42.9% | 98.8% |
| Net Profit YoY | 184.4% | 109.8% |
| EPS (diluted) | $0.12 | $7.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.4B | ||
| Q4 25 | $950.5M | $1.3B | ||
| Q3 25 | $956.0M | $1.0B | ||
| Q2 25 | $654.8M | $838.0M | ||
| Q1 25 | $620.4M | $699.0M | ||
| Q4 24 | $665.2M | $979.5M | ||
| Q3 24 | $478.7M | $738.4M | ||
| Q2 24 | $486.3M | $693.4M |
| Q1 26 | — | $322.7M | ||
| Q4 25 | $6.6M | $204.0M | ||
| Q3 25 | $373.0K | $144.6M | ||
| Q2 25 | $9.4M | $97.2M | ||
| Q1 25 | $6.7M | $146.2M | ||
| Q4 24 | $-7.8M | $140.4M | ||
| Q3 24 | $16.1M | $78.4M | ||
| Q2 24 | $19.2M | $73.8M |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 24.2% | ||
| Q3 25 | 2.0% | 20.8% | ||
| Q2 25 | 3.1% | 18.0% | ||
| Q1 25 | 3.3% | 16.0% | ||
| Q4 24 | 0.1% | 21.8% | ||
| Q3 24 | 5.9% | 16.7% | ||
| Q2 24 | 6.2% | 15.9% |
| Q1 26 | — | 23.0% | ||
| Q4 25 | 0.7% | 15.7% | ||
| Q3 25 | 0.0% | 13.8% | ||
| Q2 25 | 1.4% | 11.6% | ||
| Q1 25 | 1.1% | 20.9% | ||
| Q4 24 | -1.2% | 14.3% | ||
| Q3 24 | 3.4% | 10.6% | ||
| Q2 24 | 3.9% | 10.6% |
| Q1 26 | — | $7.20 | ||
| Q4 25 | $0.12 | $4.80 | ||
| Q3 25 | $0.01 | $3.41 | ||
| Q2 25 | $0.19 | $2.36 | ||
| Q1 25 | $0.14 | $3.48 | ||
| Q4 24 | $-0.14 | $3.32 | ||
| Q3 24 | $0.33 | $1.86 | ||
| Q2 24 | $0.40 | $1.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | — |
| Total Assets | $2.2B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $429.5M | $3.0B | ||
| Q3 25 | $463.4M | $2.4B | ||
| Q2 25 | $342.1M | $1.7B | ||
| Q1 25 | $260.9M | $1.4B | ||
| Q4 24 | $290.8M | $2.4B | ||
| Q3 24 | $350.3M | $1.8B | ||
| Q2 24 | $327.7M | $1.7B |
| Q1 26 | — | — | ||
| Q4 25 | $779.3M | $2.0B | ||
| Q3 25 | $775.5M | $1.8B | ||
| Q2 25 | $765.5M | $1.7B | ||
| Q1 25 | $745.4M | $1.5B | ||
| Q4 24 | $712.7M | $1.7B | ||
| Q3 24 | $704.6M | $1.6B | ||
| Q2 24 | $678.9M | $1.5B |
| Q1 26 | — | — | ||
| Q4 25 | $2.2B | $5.4B | ||
| Q3 25 | $2.2B | $4.4B | ||
| Q2 25 | $1.4B | $3.7B | ||
| Q1 25 | $1.3B | $3.3B | ||
| Q4 24 | $1.4B | $4.2B | ||
| Q3 24 | $1.3B | $3.6B | ||
| Q2 24 | $1.3B | $3.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | — |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -0.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $807.5M | ||
| Q3 25 | $10.0M | $560.9M | ||
| Q2 25 | $90.9M | $437.7M | ||
| Q1 25 | $16.6M | $-549.7M | ||
| Q4 24 | $-10.9M | $686.4M | ||
| Q3 24 | $34.0M | $234.5M | ||
| Q2 24 | $23.2M | $348.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $798.6M | ||
| Q3 25 | $7.4M | $541.5M | ||
| Q2 25 | $89.5M | $411.7M | ||
| Q1 25 | $13.6M | $-569.3M | ||
| Q4 24 | $-13.5M | $673.1M | ||
| Q3 24 | $31.7M | $226.6M | ||
| Q2 24 | $20.4M | $340.7M |
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | 61.6% | ||
| Q3 25 | 0.8% | 51.8% | ||
| Q2 25 | 13.7% | 49.1% | ||
| Q1 25 | 2.2% | -81.4% | ||
| Q4 24 | -2.0% | 68.7% | ||
| Q3 24 | 6.6% | 30.7% | ||
| Q2 24 | 4.2% | 49.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 0.7% | ||
| Q3 25 | 0.3% | 1.9% | ||
| Q2 25 | 0.2% | 3.1% | ||
| Q1 25 | 0.5% | 2.8% | ||
| Q4 24 | 0.4% | 1.4% | ||
| Q3 24 | 0.5% | 1.1% | ||
| Q2 24 | 0.6% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | 3.96× | ||
| Q3 25 | 26.69× | 3.88× | ||
| Q2 25 | 9.65× | 4.50× | ||
| Q1 25 | 2.48× | -3.76× | ||
| Q4 24 | — | 4.89× | ||
| Q3 24 | 2.11× | 2.99× | ||
| Q2 24 | 1.21× | 4.72× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
EVR
| Advisory Fees (1) | $1.2B | 89% |
| Commissions and Related Revenue | $62.7M | 4% |
| Underwriting Fees | $55.1M | 4% |
| Asset Management and Administration Fees (2) | $23.7M | 2% |
| Other Revenue, net | $15.4M | 1% |
